Latest Updates

Leaders at the Centers for Medicare and Medicaid Services are exploring proposals to limit health insurers’ use of tactics that can delay medical care, people familiar with the discussions said.

NEW YORK, April 29, 2025--(BUSINESS WIRE)--The 39th Barometer from Sermo, a fast, frictionless HCP engagement platform providing the healthcare industry with real-time business insights and authentic physician touch points, found that the majority (80%) of surveyed oncologists report that they always, often, or sometimes encounter delays in treatment initiation due to prior authorization requirements.

Hello. I’m Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School and Old Dominion University in Norfolk, Virginia.

The Community Oncology Alliance (COA) kicks off its annual 2025 Community Oncology Conference today, convening thousands of independent cancer leaders in Orlando, Florida. As the nation’s only nonprofit organization focused solely on the needs of independent community practices, COA’s mission is to ensure that patients with cancer receive local, affordable, cutting-edge, and high-quality care.

The Trump administration wants the healthcare industry to recommend rules and regulations to toss. Trade groups representing hospitals, health insurance companies and others have ideas.

WASHINGTON — Soon after returning from their spring break, congressional Republicans will have to start making some tough choices.

Merck & Co. will grow its U.S. manufacturing footprint with a $1 billion plant in Delaware, becoming the latest drugmaker to invest in the U.S. as tariffs targeting the industry loom. The facility’s products will include biologic drugs and a new, easier-to-use version of Keytruda, the company’s blockbuster cancer drug. The plant marks Merck’s first in-house manufacturing site in the U.S. to make Keytruda, and will ensure American patients get the drug made domestically.

The Iowa Senate has passed legislation aimed at preventing rural pharmacy closures, but some opponents say it could increase health care costs for Iowans.

The National Community Pharmacists Association wants Elon Musk's Department of Government Efficiency to help it fight the pharmacy benefit managers.

LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a report commissioned by the industry's U.S. trade group and reviewed by Reuters shows.